- Home
- ESPR vs FRPH Comparison
ESPR vs FRPH Comparison
Compare ESPR & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- FRPH
- Stock Information
- Founded
- ESPR 2008
- FRPH 1986
- Country
- ESPR United States
- FRPH United States
- Employees
- ESPR N/A
- FRPH N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- ESPR Health Care
- FRPH Finance
- Exchange
- ESPR Nasdaq
- FRPH Nasdaq
- Market Cap
- ESPR 534.3M
- FRPH 482.5M
- IPO Year
- ESPR 2013
- FRPH N/A
- Fundamental
- Price
- ESPR $2.55
- FRPH $23.86
- Analyst Decision
- ESPR Buy
- FRPH
- Analyst Count
- ESPR 6
- FRPH 0
- Target Price
- ESPR $6.50
- FRPH N/A
- AVG Volume (30 Days)
- ESPR 7.0M
- FRPH 59.0K
- Earning Date
- ESPR 11-06-2025
- FRPH 11-05-2025
- Dividend Yield
- ESPR N/A
- FRPH N/A
- EPS Growth
- ESPR N/A
- FRPH N/A
- EPS
- ESPR N/A
- FRPH 0.28
- Revenue
- ESPR $268,125,000.00
- FRPH $32,293,999.00
- Revenue This Year
- ESPR $13.05
- FRPH N/A
- Revenue Next Year
- ESPR N/A
- FRPH N/A
- P/E Ratio
- ESPR N/A
- FRPH $86.26
- Revenue Growth
- ESPR N/A
- FRPH 3.18
- 52 Week Low
- ESPR $0.69
- FRPH $23.52
- 52 Week High
- ESPR $3.94
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- ESPR 47.71
- FRPH 35.56
- Support Level
- ESPR $2.35
- FRPH $23.52
- Resistance Level
- ESPR $3.41
- FRPH $24.48
- Average True Range (ATR)
- ESPR 0.18
- FRPH 0.47
- MACD
- ESPR -0.03
- FRPH -0.00
- Stochastic Oscillator
- ESPR 9.79
- FRPH 23.86
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).